Rare Classroom: Narcolepsy
source: shutterstock

Rare Classroom: Narcolepsy

Welcome to the Rare Classroom, a new series from Patient Worthy. Rare Classroom is designed for the curious reader who wants to get informed on some of the rarest, most…

Continue Reading Rare Classroom: Narcolepsy
Xywav for Idiopathic Hypersomnia Earns Orphan Drug Exclusivity
https://pixabay.com/en/baby-girl-sleep-child-toddler-1151351/

Xywav for Idiopathic Hypersomnia Earns Orphan Drug Exclusivity

Orphan Drug designation is typically granted to drugs or biologics intended to treat, prevent, or diagnose rare diseases; in the United States, these are conditions affecting under 200,000 Americans. Drug…

Continue Reading Xywav for Idiopathic Hypersomnia Earns Orphan Drug Exclusivity
Rare Classroom: Narcolepsy
source: shutterstock

Rare Classroom: Narcolepsy

Welcome to the Rare Classroom, a new series from Patient Worthy. Rare Classroom is designed for the curious reader who wants to get informed on some of the rarest, most…

Continue Reading Rare Classroom: Narcolepsy

A New Opportunity for Narcolepsy Patients

Acknowledgment: This story is sponsored by Takeda and is promoted through the Patient Worthy Collaborative Content program. We only publish content that embodies our mission of providing relevant, vetted and valuable information to the…

Continue Reading A New Opportunity for Narcolepsy Patients

The Struggles of being a Rare Disease Patient in China

The State of Rare Diseases in China The Illness Challenge Foundation (ICF) is an organization devoted to easing the burdens that rare disease patients living in China face. They accomplish this…

Continue Reading The Struggles of being a Rare Disease Patient in China